These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

774 related articles for article (PubMed ID: 24462078)

  • 21. Does portal-superior mesenteric vein invasion still indicate irresectability for pancreatic carcinoma?
    Ramacciato G; Mercantini P; Petrucciani N; Giaccaglia V; Nigri G; Ravaioli M; Cescon M; Cucchetti A; Del Gaudio M
    Ann Surg Oncol; 2009 Apr; 16(4):817-25. PubMed ID: 19156463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes.
    Martin RC; Scoggins CR; Egnatashvili V; Staley CA; McMasters KM; Kooby DA
    Arch Surg; 2009 Feb; 144(2):154-9. PubMed ID: 19221327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatectomy and pancreatectomy with combined vascular resection in patients with hepato-biliary and pancreas diseases at a single cancer institute.
    Nanashima A; Yamaguchi H; Sumida Y; Abo T; Tobinaga S; Tanaka K; Takeshita H; Hidaka S; Sawai T; Yasutake T; Nagayasu T
    Hepatogastroenterology; 2008; 55(84):873-8. PubMed ID: 18705286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
    Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C
    Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prosthetic graft reconstruction after portal vein resection in pancreaticoduodenectomy: a multicenter analysis.
    Chu CK; Farnell MB; Nguyen JH; Stauffer JA; Kooby DA; Sclabas GM; Sarmiento JM
    J Am Coll Surg; 2010 Sep; 211(3):316-24. PubMed ID: 20800187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefit of portal or superior mesenteric vein resection with adjuvant chemotherapy for patients with pancreatic head carcinoma.
    Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Kondo N; Nakagawa N; Sueda T
    J Surg Oncol; 2013 Mar; 107(4):414-21. PubMed ID: 22886567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: a meta-analysis.
    Yu XZ; Li J; Fu DL; Di Y; Yang F; Hao SJ; Jin C
    Eur J Surg Oncol; 2014 Apr; 40(4):371-8. PubMed ID: 24560302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Planned versus unplanned portal vein resections during pancreaticoduodenectomy for adenocarcinoma.
    Kim PT; Wei AC; Atenafu EG; Cavallucci D; Cleary SP; Moulton CA; Greig PD; Gallinger S; Serra S; McGilvray ID
    Br J Surg; 2013 Sep; 100(10):1349-56. PubMed ID: 23939847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie.
    Delpero JR; Boher JM; Sauvanet A; Le Treut YP; Sa-Cunha A; Mabrut JY; Chiche L; Turrini O; Bachellier P; Paye F
    Ann Surg Oncol; 2015; 22(6):1874-83. PubMed ID: 25665947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcome of portomesenteric vein invasion and prognostic factors in pancreas head adenocarcinoma.
    Jeong J; Choi DW; Choi SH; Heo JS; Jang KT
    ANZ J Surg; 2015 Apr; 85(4):264-9. PubMed ID: 24641800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy.
    van Geenen RC; ten Kate FJ; de Wit LT; van Gulik TM; Obertop H; Gouma DJ
    Surgery; 2001 Feb; 129(2):158-63. PubMed ID: 11174708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreaticoduodenectomy with vascular resection: margin status and survival duration.
    Tseng JF; Raut CP; Lee JE; Pisters PW; Vauthey JN; Abdalla EK; Gomez HF; Sun CC; Crane CH; Wolff RA; Evans DB
    J Gastrointest Surg; 2004 Dec; 8(8):935-49; discussion 949-50. PubMed ID: 15585381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors influencing outcome in patients undergoing portal vein resection for adenocarcinoma of the pancreas.
    Banz VM; Croagh D; Coldham C; Tanière P; Buckels J; Isaac J; Mayer D; Muiesan P; Bramhall S; Mirza DF
    Eur J Surg Oncol; 2012 Jan; 38(1):72-9. PubMed ID: 22054617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric venous invasion.
    Han S; Choi DW; Choi SH; Heo JS; Han IW; You YH
    Asian J Surg; 2021 Jan; 44(1):313-320. PubMed ID: 32972828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indications and techniques of extended resection for pancreatic cancer.
    Nakao A; Takeda S; Inoue S; Nomoto S; Kanazumi N; Sugimoto H; Fujii T
    World J Surg; 2006 Jun; 30(6):976-82; discussion 983-4. PubMed ID: 16736324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One Hundred Pancreatectomies with Venous Resection for Pancreatic Adenocarcinoma.
    Dumitrascu T; Martiniuc A; Brasoveanu V; Stroescu C; David L; Dima S; Stanciulea O; Ionescu M; Popescu I
    Chirurgia (Bucur); 2018; 113(3):363-373. PubMed ID: 29981667
    [No Abstract]   [Full Text] [Related]  

  • 37. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct percutaneous transhepatic portomesenteric venous stenting in management of locally advanced pancreatic cancer.
    Alden D; Dudiy Y; Nassiri N; Friedland RJ; Amatulle P; Rosen RJ
    Am J Clin Oncol; 2015 Apr; 38(2):127-9. PubMed ID: 23608832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of portal-superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head cancer.
    Han SS; Park SJ; Kim SH; Cho SY; Kim YK; Kim TH; Lee SA; Woo SM; Lee WJ; Hong EK
    Pancreas; 2012 Jan; 41(1):102-6. PubMed ID: 21775914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of portosystemic shunts during extended pancreatic resections.
    Oehme F; Distler M; Müssle B; Kahlert C; Weitz J; Welsch T
    Langenbecks Arch Surg; 2019 Dec; 404(8):959-966. PubMed ID: 31446472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.